New LaunchApr 22, 2026, 08:01 AM
Stereotaxis' MAGiC Catheter Treats First US Patient Post-FDA Approval
AI Summary
Stereotaxis announced the successful treatment of the first US patient using its MAGiC™ robotically-navigated magnetic interventional cardiac ablation catheter. The MAGiC catheter, recently FDA PMA approved, is specifically designed for arrhythmia in patients with complex congenital heart disease. The initial procedure at Oregon Health & Science University successfully treated a patient with challenging anatomy, who had previously failed manual ablation attempts, with no recurrence weeks post-procedure. This marks a significant advancement in treating complex arrhythmia patients.
Key Highlights
- MAGiC, Stereotaxis' robotically-navigated catheter, treated its first US patient.
- The catheter received FDA PMA approval for complex congenital heart disease.
- First patient had complex congenital heart disease and frequent atrial flutter.
- Previous manual ablation attempts were unsuccessful due to challenging anatomy.
- Patient has not experienced recurrence weeks after the MAGiC procedure.
Price Impact
More from STXS